We’re looking for collaborators who have access to patient-level data and are interested in providing evidence on the effects of direct oral anticoagulants (DOACs) to the healthcare community.
The study aims to directly compare the effectiveness and safety outcomes between all DOACs (dabigatran, rivaroxaban, apixaban, and edoxaban) in patients with atrial fibrillation using multi-national databases. The background of the study was presented in the OHDSI Collaborator Team Meeting in June where we’ve received your helpful feedback (thank you!): https://www.ohdsi.org/wp-content/uploads/2020/06/OHDSI-community-meeting_20200609_DOAC.pdf)
@CarmenOT and team have joined the study and have been kindly helping with this project. The study requirement and instructions on how to run the study can be found at https://github.com/ohdsi-studies/Corazon
Please send an email with title “corazon results” to Carmen O. Torre to notify you have dropped results in the folder or to send your “Result_.zip”.
Thank you and we hope you will join the study!